Moscow, Russia

Sergey Mikhailov



 

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 2001-2009

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Sergey Mikhailov

Introduction

Sergey Mikhailov is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of bisphosphonate conjugates. With a total of 4 patents to his name, Mikhailov's work focuses on innovative treatments for bone-related diseases.

Latest Patents

Mikhailov's latest patents include groundbreaking inventions such as "Bisphosphonate conjugates and methods of making and using the same." This invention provides novel bisphosphonate conjugates, pharmaceutical compositions comprising these conjugates, and methods for using them in the treatment of bone cancer and other bone-related diseases. Another significant patent is "Biphosphonate conjugates and methods of making and using the same," which is directed towards specific bisphosphonate compounds that are useful in treating soft tissues surrounding bones and conditions like osteoporosis.

Career Highlights

Throughout his career, Mikhailov has worked with various companies, including MBC Research, Inc. and MBC Pharma, Inc. His expertise in pharmaceutical research has led to advancements in treatments that address critical health issues related to bones and soft tissues.

Collaborations

Mikhailov has collaborated with notable professionals in his field, including Nelly Padioukova and Grigorii Tzeitline. These collaborations have further enhanced his research and development efforts.

Conclusion

Sergey Mikhailov's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical treatments for bone-related diseases. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…